[Hachimijiogan having no estrogenic activity is effective for senile colpitis].
The effects of Hachimijiogan, a Chinese medicine, were studied in patients with senile colpitis. Eighty-eight postmenopausal patients, aged 42-76 years, were treated. Hachimijiogan was effective in 65 of 66 cases with abnormal discharge, 10 of 11 with pruritus vaginae and 60 of 62 with subepithelial hemorrhage. Overall more than ninety per cent of the patients responded well. The serum FSH, E1 and E2 levels were not statistically changed in this treatment. The vaginal Pap smear showed a significant decrease in parabasal type cells and an increase in intermediate type cells (p less than 0.01). Radioimmunoassay of E1, E2, E3, testosterone, FSH, LH and prolactin in Hachimijiogan were below the levels of sensitivity. These data suggest that Hachimijiogan is effective for senile colpitis and patients with senile colpitis associated with estrogen dependent tumors could be safely treated by Hachimijiogan.
D000368:Aged; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000032:analysis / Q000627:therapeutic use*; D004967:Estrogens / Q000097:blood; D005069:Evaluation Studies as Topic; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D014627:Vaginitis / Q000188:drug therapy* / Q000473:pathology
D004365:Drugs, Chinese Herbal; D004967:Estrogens; D005640:Follicle Stimulating Hormone